Showing results (91-100 of 199) with videos related to
Sort By:
Pageof 20
Bone Marrow Transplantation|June 25, 2024
Longitudinal outcome over four decades of allogeneic stem cell transplantation: a single center experienceMiguel Ángel Sanz, Juan Montoro, Aitana Balaguer-Roselló, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2018
Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II TrialMeletios Dimopoulos, Katja Weisel, Niels W C J van de Donk, et al.European Journal of Haematology|July 17, 2015
Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myelomaFrancisco Javier Peñalver, Julio Delgado, Javier Loscertales, et al.Health Science Reports|January 31, 2019
Bortezomib retreatment for relapsed and refractory multiple myeloma in real-world clinical practiceCyrille Hulin, Javier de la Rubia, Meletios A Dimopoulos, et al.British Journal of Haematology|July 22, 2008
Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort studyJulio del Río-Garma, Alberto Alvarez-Larrán, Clara Martínez, et al.Cancers|April 23, 2022
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational StudyAntonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, et al.Haematologica|September 4, 2025
Genetic risk classification in acute myeloid leukemia patients treated with hematopoietic cell transplantation and post-transplant cyclophosphamideMarta Villalba, Juan Montoro, Aitana Balaguer-Roselló, et al.Transplantation and Cellular Therapy|July 11, 2025
Mold Invasive Fungal Infection in Hematopoietic Cell Transplant With Post-Transplant Cyclophosphamide and Posaconazole ProphylaxisPedro Chorão, Pablo Granados, Pilar Calvillo-Batllés, et al.Blood|March 27, 2007
CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donorsArianne Pérez-García, Rafael De la Cámara, Jose Román-Gómez, et al.European Journal of Haematology|July 21, 2018
Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practiceEvangelos Terpos, Eirini Katodritou, Javier de la Rubia, et al.Pageof 20